Clinical trial

Lapatinib Resistance in Patients With Breast Cancer

NCT00898573

StatusWITHDRAWN

Study typeOBSERVATIONAL

Start date2008-07-01

PhaseN/A

Study timeline

Study start (unknown)2008-07-01Date precision: month

Registry last updated2015-10-02

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Interventions

lapatinib ditosylateDRUG · verified · RxNorm: lapatinib ditosylate

fluorescence in situ hybridizationGENETIC

gene expression analysisGENETIC

mutation analysisGENETIC

polymerase chain reactionGENETIC

reverse transcriptase-polymerase chain reactionGENETIC

cell sortingOTHER

immunohistochemistry staining methodOTHER

laboratory biomarker analysisOTHER

Sponsors & collaborators

Case Comprehensive Cancer Centerlead sponsor

National Cancer Institute (NCI)collaborator

Mapped research locations

ClevelandOhio, United States9

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00898573 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.